GGrantIndex
Sort

50,496 grants matching lung cancer

Gene Methylation and Therapeutic Response in Lung Cancer

$582,730
Lovelace Biomedical &Environmental Res · R01 · FY2001 · CA

Molecular mechanisms underlying lineage plasticity in prostate cancer

$582,713
Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2023 · CA

Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation

$582,707
Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2018 · DE

UCLA Pulmonary and Critical Care Medicine Training Program

$582,670
Steven M. Dubinett · University Of California Los Angeles · T32 · FY2023 · HL

Geisinger Clinical Oncology Program

$582,640
Geisinger Medical Center · U10 · FY2003 · CA

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$582,570
Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2017 · CA

Temporal and Spatial Signaling in Chemotaxis

$582,503
Peter N Devreotes · Johns Hopkins University · R01 · FY2014 · GM

Temporal and Spatial Signaling in Chemotaxis

$582,502
Peter N Devreotes · Johns Hopkins University · R01 · FY2012 · GM

Biomarkers of NNK in prediction of lung cancer development in smokers

$582,501
Jian-Min Yuan · University Of Minnesota · R01 · FY2009 · CA

Temporal and Spatial Signaling in Chemotaxis

$582,498
Peter N Devreotes · Johns Hopkins University · R01 · FY2011 · GM

Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation

$582,464
Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2017 · DE

Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA

$582,455
Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Construal level as a novel pathway for affect regulation and cancer control

$582,362
Elliot Todd Berkman · University Of Oregon · R01 · FY2022 · CA

Leveraging canine spontaneous cancer to optimize the power of blood biopsy

$582,347
Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA

Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients

$582,287
Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2021 · CA

Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer

$582,266
Marcin Imielinski · Weill Medical Coll Of Cornell Univ · R37 · FY2022 · CA

CatheterScope for Intraluminal Image of Early.Neoplasia

$582,224
University Of Washington · R33 · FY2005 · CA

A NOVEL AGENT FOR LUNG CANCER PREVENTION

$582,129
Pennsylvania State University · · FY2019 · Defense Health Agency

Targeting plasticity in lung cancer

$582,097
Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Interrogating roles for REST in small cell lung cancer therapy response and resistance

$582,076
David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Interrogating roles for REST in small cell lung cancer therapy response and resistance

$582,076
David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer

$582,047
Paul D Lampe · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

New Electrographic Biomarkers of Epileptogenesis

$581,821
Anatol Bragin · University Of California Los Angeles · R01 · FY2015 · NS

New Electrographic Biomarkers of Epileptogenesis

$581,821
Anatol Bragin · University Of California Los Angeles · R01 · FY2016 · NS

New Electrographic Biomarkers of Epileptogenesis

$581,821
Anatol Bragin · University Of California Los Angeles · R01 · FY2017 · NS